<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Bleiber G</dc:creator>
  <dc:creator>Peters S</dc:creator>
  <dc:creator>Martinez R</dc:creator>
  <dc:creator>Cmarko D</dc:creator>
  <dc:creator>Meylan P</dc:creator>
  <dc:creator>Telenti A</dc:creator>
  <dc:date>2004</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">The human immunodeficiency virus type 1 p6 region encodes p6(Gag) and the transframe p6(Pol) protein. The Gag frame encodes an N-terminal late assembly L domain and a C-terminal Vpr binding domain. In the Pol frame, substitution at a C-terminal motif decreases protease autocleavage. The role of the highly polymorphic central region of p6, comprising amino acids S14-I31 (p6(Gag)) and R20-D39 (p6(Pol)), is unclear. Analysis of this central region demonstrated that 35 % of p6(Gag) appears to be dispensable for virus propagation in vitro and smaller deletion and insertion polymorphisms can be tolerated in vivo. Extensive Pol deletion (deltaR20-D39, 42 % of p6(Pol)) did not alter protease autocleavage.</dc:description>
  <dc:identifier>https://sonar.ch/global/documents/8092</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1099/vir.0.19576-0</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/15039534</dc:relation>
  <dc:source>The Journal of general virology. - 2004</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Amino Acid Sequence</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Gene Products, gag</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Gene Products, pol</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">HIV Infections</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">HIV-1</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">In Vitro Techniques</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Molecular Sequence Data</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Phenotype</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Polymorphism, Genetic</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Recombination, Genetic</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Sequence Deletion</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Virulence</dc:subject>
  <dc:subject xmlns:ns14="xml" ns14:lang="en">Virus Replication</dc:subject>
  <dc:title xmlns:ns15="xml" ns15:lang="en">The central region of human immunodeficiency virus type 1 p6 protein (Gag residues S14-I31) is dispensable for the virus in vitro.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
